Analyst Ranking
Bottom 8%
#4668 out of 5018 analysts
Average Return
-0.94%
Win Rate
43%115 out of 270
Risk vs Reward
Poor
Good

Brian Abrahams's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
89bio IncETNB
+558.80%$2.67$17.59
2022-05-11 -
2023-05-11
Buy
Pliant Therapeutics IncPLRX
+382.01%$4.67$22.51
2022-05-09 -
2023-05-09
Buy
Ambrx Biopharma IncAMAM
+233.33%$8.40$28.00
2023-10-22 -
2024-03-06
Buy
Mind Medicine IncMNMD
+222.26%$3.01$9.70
2023-03-09 -
2024-03-08
Buy
Ambrx Biopharma IncAMAM
+210.77%$9.01$28.00
2023-11-13 -
2024-03-06
Buy

Brian Abrahams's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Atyr Pharma IncATYR
1Hold$1.50+38.89%Downgrades
2 days ago
Kymera Therapeutics IncKYMR
1Buy$70.00+43.50%Initiates Coverage On
2 days ago
Neurocrine Biosciences IncNBIX
21Buy$149.00+5.75%Maintains
12 days ago
Sionna Therapeutics IncSION
1Hold$22.00-5.46%Initiates Coverage On
15 days ago
Xenon Pharmaceuticals IncXENE
16Buy$55.00+54.23%Reiterates
16 days ago
Aardvark Therapeutics IncAARD
4Buy$19.00+85.19%Maintains
a month ago
Ptc Therapeutics IncPTCT
17Buy$63.00+5.55%Maintains
a month ago
Gilead Sciences IncGILD
30Hold$98.00-11.60%Maintains
a month ago
89bio IncETNB
14Hold$11.00+38.02%Maintains
a month ago
Acadia Pharmaceuticals IncACAD
2Buy$40.00+66.94%Maintains
a month ago
Vertex Pharmaceuticals IncVRTX
54Hold$405.00+3.49%Maintains
a month ago
Prothena Corp Public Ltd CoPRTA
11Hold$10.00+22.55%Maintains
a month ago
Regeneron Pharmaceuticals IncREGN
33Hold$695.00+20.86%Maintains
a month ago
Biogen IncBIIB
37Buy$219.00+52.42%Maintains
2 months ago
Incyte CorpINCY
21Hold$72.00-14.18%Maintains
2 months ago
Sarepta Therapeutics IncSRPT
31Hold$23.00+27.07%Maintains
2 months ago
Biocryst Pharmaceuticals IncBCRX
15Buy$13.00+67.74%Reiterates
3 months ago
Cidara Therapeutics IncCDTX
1Buy$75.00+15.90%Maintains
3 months ago
Moonlake ImmunotherapeuticsMLTX
2Buy$67.00+25.80%Reiterates
3 months ago
Contineum Therapeutics IncCTNM
5Buy$31.00+161.05%Reiterates
4 months ago
Applied Therapeutics IncAPLT
6Hold$1.50+248.84%Reiterates
4 months ago
Karyopharm Therapeutics IncKPTI
11Buy$33.00+427.16%Maintains
4 months ago
Corbus Pharmaceuticals Holdings IncCRBP
7Buy$58.00+464.75%Maintains
4 months ago
Legend Biotech CorpLEGN
1Buy$84.00+144.61%Reiterates
5 months ago
Gh Research PLCGHRS
1Buy$31.00+145.45%Initiates Coverage On
6 months ago
Pliant Therapeutics IncPLRX
13Hold$3.00+96.08%Maintains
6 months ago
Neumora Therapeutics IncNMRA
6Hold$4.00+166.67%Reiterates
6 months ago
Axsome Therapeutics IncAXSM
2Buy$143.00+25.33%Maintains
7 months ago
Newamsterdam Pharma Co NvNAMS
1Buy$40.00+63.13%Reiterates
8 months ago
Intra Cellular Therapies IncITCI
17Hold$132.00+0.10%Downgrades
8 months ago
Igm Biosciences IncIGMS
15Hold$1.50+18.11%Downgrades
8 months ago
Hookipa Pharma IncHOOK
11Hold$2.00+127.01%Downgrades
9 months ago
Sage Therapeutics IncSAGE
19Hold$4.00-53.92%Upgrades
10 months ago
Galapagos NvGLPG
10Hold$30.00-6.31%Maintains
a year ago
Marinus Pharmaceuticals IncMRNS
8Hold$1.00+81.82%Maintains
a year ago
Mind Medicine IncMNMD
9Buy$22.00N/AReiterates
a year ago
Ambrx Biopharma IncAMAM
3Buy$32.00N/AMaintains
2 years ago
Karuna Therapeutics IncKRTX
7Buy$225.00N/AMaintains
2 years ago
Enanta Pharmaceuticals IncENTA
14Hold$15.00N/AMaintains
2 years ago
Intercept Pharmaceuticals IncICPT
11Hold$19.00N/AMaintains
2 years ago
Atai Life Sciences NvATAI
3Hold$9.00N/AMaintains
3 years ago
Merus NvMRUS
3Hold$33.00N/AMaintains
4 years ago
Constellation Pharmaceuticals IncCNST
1Hold$34.00N/ADowngrades
4 years ago
Metacrine IncMTCR
1Buy$25.00N/AInitiates Coverage On
5 years ago
Neubase Therapeutics IncNBSE
1Buy$320.00N/AInitiates Coverage On
5 years ago
Celgene CorpCELG
2Buy$118.00N/ADowngrades
7 years ago
Ultragenyx Pharmaceutical IncRARE
2Strong BuyN/AN/AUpgrades
8 years ago
Epizyme IncEPZM
1HoldN/AN/ADowngrades
8 years ago
Alder Biopharmaceuticals IncALDR
1Buy$17.00N/AInitiates Coverage On
8 years ago
Immune Design CorpIMDZ
1Buy$20.00N/AInitiates Coverage On
8 years ago
Avexis IncAVXS
1Hold$92.00N/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.